ReportGem ReportGem EN

普通外文研报

Best Smidcap Ideas: ESTA-blishing a New Standard in Breast Augmentation

发布日期: 2026-06-18研究机构: TD Cowen公司 / 股票: ESTA.OQ报告页数: 12原文语言: 英语证据页码: 3

研报英文原文证据摘录

Best Smidcap Ideas: ESTA-blishing a New Standard in Breast Augmentation

ultiple surgeons highlighted a rapidly growing

population of women experiencing breast volume loss, upper pole deflation, and tissue

changes that closely resemble post-pregnancy or post-breastfeeding anatomy following

even modest weight reduction. Importantly, many of these patients are not seeking large-

volume augmentation but rather subtle restoration of breast shape and structure. This aligns

exceptionally well with Motiva, Preservé, and eventually Mia, all of which emphasize natural

aesthetics, smaller implant volumes, tissue preservation, and less invasive recovery profiles.

Several surgeons noted that GLP-1 usage has become so prevalent among their patient

populations that it is now a routine component of the consultation process. We believe the

emergence of millions of women experiencing breast deflation secondary to weight loss creates

a significant new demand pool for breast enhancement procedures, positioning Establishment

Labs as one of the most direct beneficiaries of the GLP-1 trend within aesthetics.

Preservé May Permanently Alter Historical Breast Augmentation Seasonality

Another overlooked aspect of the story is Preservé's potential to fundamentally reshape the

seasonality profile of the breast augmentation market. Historically, procedure demand has

slowed meaningfully during summer months as patients sought to avoid extended recovery

periods that limited travel, swimming, exercise, and outdoor activities. Several surgeons noted

that traditional breast augmentation demand would typically decline after Memorial Day

and remain subdued until Labor Day. However, physicians are now reporting robust Preservé

本摘录由系统从所标注的 PDF 证据页直接提取并保留英文原文,不做批量翻译;登录后在阅读器切换中文时才按需翻译。

打开研报阅读器